University of Arkansas, Fayetteville

ScholarWorks@UARK
Biomedical Engineering Undergraduate Honors
Theses

Biomedical Engineering

5-2016

Determining the Effect of Delivery Rate on Glucose Uptake by
Cancer Cells
Luke Felton
University of Arkansas, Fayetteville

Follow this and additional works at: https://scholarworks.uark.edu/bmeguht
Part of the Bioimaging and Biomedical Optics Commons

Citation
Felton, L. (2016). Determining the Effect of Delivery Rate on Glucose Uptake by Cancer Cells. Biomedical
Engineering Undergraduate Honors Theses Retrieved from https://scholarworks.uark.edu/bmeguht/36

This Thesis is brought to you for free and open access by the Biomedical Engineering at ScholarWorks@UARK. It
has been accepted for inclusion in Biomedical Engineering Undergraduate Honors Theses by an authorized
administrator of ScholarWorks@UARK. For more information, please contact scholar@uark.edu.

Determining the Effect of Delivery Rate on Glucose Uptake by Cancer Cells
Luke Felton
University of Arkansas, Fayetteville
May 2016
Abstract
Radiation therapy is one of the most commonly performed cancer treatment
therapies today. Radiation therapy can cause can changes to tumor vasculature and
affect blood flow rates. It is important to determine how changes in blood flow rates
affect tumor glycolytic uptake to better understand tumor response to radiation
therapy (1). The goal of this study was to use a fluorescent analog of glucose, 2NBDG, to study the effect of varying flow rates on glucose uptake. A microfluidic
device was constructed to flow 2-NBDG through. A murine metastatic breast cancer
cell line was then cultured inside this microfluidic channel, and 2-NBDG was flowed
through the device at .5 microliters/min for 20 minutes. After 20 minutes, the
device was imaged using fluorescence microscopy. The 2-NBDG uptake was
measured for only one flow rate. This is not sufficient evidence to determine the
effect of varying flow rates on glucose uptake. Future studies should be conducted at
increasing flow rates to determine this effect.
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Introduction

One characteristic of cancer cells is heightened glucose uptake in comparison to
normal cells. Quantifying the glucose uptake has been helpful in identifying cancers,
and determining the effect of radiation therapy. Positron emission tomography has
been a widely used imaging technique to quantify glucose uptake in the clinic.
Though widely used, this method provides limited information concerning the
metabolism of a tumor. This technique only provides the glucose uptake at a single
point in time. The glucose uptake at that point in time cannot be indicative of tumor
metabolic activity because glucose uptake can be affected by multiple factors.
Glucose uptake can be perfusion dependent, influenced by varying flow rates, and
dependent on the actual metabolic need for the tumor. Because the post-radiation
tumor microenvironment can cause severe changes to the tumor microvasculature
and hence affect the delivery of contrast agents, it is important to understand the
effect of blood flow rates on the uptake of glucose analogs. The initial glucose uptake
of the tumor provides insight into the metabolic demand of the tumor, helping to
quantify tumor metastatic potential and tumor response to radiation therapy. It is
important to determine the effect of varying flow rates to determine the actual
metabolic demand of the tumor (1).
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It has been shown in the figure above that 2-NBDG uptake is correlated with blood
velocity. In this in vivo study, mice were injected with breast cancer cells to form a
tumor. These mice were then subject to hypoxic conditions, and the blood velocity
of the tumor and the glucose uptake (Rd) were measured before and after hypoxia.
The study showed that as the blood velocity increased, the delivery rate of glucose
increased, suggesting that 2-NBDG uptake is dependent on flow rate. This study has
been the motivation for our study (2). The goal of our study was to isolate the effect
varying flow rates on glucose uptake so that more information on initial metabolic
demand of tumors could be determined. We used a fluorescent glucose analog, 2NBDG, to measure glucose uptake in murine breast cancer cells. This analog was
chosen because it has shown to be a suitable molecule for measuring glucose uptake
in previous studies. This study was sectioned into three main aims: to create a
suitable device for 2-NBDG to flow, to model in vivo parameters by seeding cells
inside the device and flowing 2-NBDG at flow rates similar to that of tumor
vasculature, and to quantify 2-NBDG uptake through fluorescence imaging. The
study of how this tracer is affected with varying flow rates will provide valuable
3

information concerning the identification of radiation resistance and radiotherapy
response, and will serve as a valuable model for future in vivo studies.

Methods

Microfluidic channel fabrication
The microfluidic channels were fabricated using a silicone wafer constructed
at the High Density Electronic Center, located at the University of Arkansas. This
wafer was made using soft lithography techniques with a channel mold and
photoresist grafting technique. This silicone wafer was designed to construct a
channel with a width of 500 microns and a depth of 50 microns. (3). 65 grams of the
PDMS elastomer base was mixed with 6.5 grams of the elastomer curing agent (10:1
ratio). The mixture was mixed vigorously for 10 minutes. After 10 minutes, the
mixture was degassed and poured over the silicone wafer. The PDMS poured over
the wafer was then placed in a 70°C oven for 3 hours to cure the PDMS. Once cured,
the PDMS was peeled from the silicone wafer and cut into two rectangular shapes
using a glass coverslip as a guide. The portholes were then made with a biopsy
punch. The PDMS molds were then sonicated for 30 minutes in 100 ml of 50% pure
ethanol and 50% deionized water and then dried with air. The molds and two glass
coverslips were then placed inside an UV/Ozone machine for 15 minutes. After 15
minutes, the glass coverslips and PDMS were attached by gently pressing each
PDMS mold onto the coverslip. To better seal the attachment of the glass coverslip
and mold, PDMS was used to surround the coverslip. 15 grams of the PDMS
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elastomer base was mixed with 1.5 grams of the elastomer curing agent. This
solution was mixed for 10 minutes and degassed. This mixture was used to
surround the entire parameter of the coverslip with a 1 ml syringe. After coated
with the PDMS mixture, the device was placed in a 70°C oven for 3 hours to cure the
surrounding PDMS. Once cured, the excess PDMS was removed so that the channel
could be easily seen inside the coverslip.

Figure 1. Microfluidic channel. The channel is formed by attaching a PDMS mold to a
glass coverslip. The cells are then cultured on the coverslip.
Cell culturing
4T1 cells, a metastatic murine breast cancer cell line, were used for these
experiments. 4T1 cells were cultured in DMEM with the addition of 10% fetal
bovine serum and 1% antibiotics. Prior to channel injection, 20mM of Hepes was
added to the cell suspension. Gelatin was injected inside the channel prior to
injecting cells. The gelatin remained in the channel for 1 hour before injecting cells.
The cells were injected inside the channel using a small piece of tygon tubing and a
syringe. The cells were then incubated at 37°C for 90 minutes. After 90 minutes, the
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cells were perfused with DMEM at 1 microliter/hour for 24-48 hours inside the
incubator. After the incubation period, the cells were imaged with 2-NBDG.

Imaging with 2-NBDG
2-NBDG fluorescence was measured using traditional fluorescence
microscopy. The image platform consisted of an inverted fluorescence microscope,
the Olympus IX-81. The microscope consisted of a 100-watt halogen lamp, used for
transmission microscopy. In addition, the microscope consisted of a 100-watt
mercury lamp used for epiflourescent microscopy. The components of the
microscope consisted of a reducer lens, two-piece collimating adapter, a liquid
crystal tunable filter, and a CCD. 2-NBDG excites at 465nm, and emits at 540nm (4).
2-NBDG was excited with a FITC filter, and imaged with an Olympus camera. 300
microliters of 2-NBDG dissolved in glucose free media (10:1 ratio) was flowed
through the channel at .5 microliters/min for 20 minutes. After 20 minutes, the cells
were washed with glucose free media to remove any excess 2-NBDG before imaging.
The cells were imaged with an integration time of 1s.
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Figure 2. Imaging platform.

Results and Discussion

Smaller port size and PDMS coating decreases device leakage
Several adjustments to the device were made to inhibit leakage of fluid from
the device. High amounts of leakage occurred at the inlet and outlet ports of the
device, and at the bottom of the device. This leakage was due to high amounts of
pressure occurring within the channel, especially at the ports. This leakage became
problematic, and resulted in eventual coverslip detachment from the PDMS. Several
structural changes to the device decreased device leakage, helping to promote
device attachment, and preventing coverslip detachment from PDMS. First, the inlet
and outlet port of the channel was decreased in size. The port size was decreased
from 1/8 inch in diameter to .75mm in diameter. This decreased the amount of
pressure due to accumulation of fluid at the ports. Second, PDMS was cured around
7

the glass coverslip to seal the bond between the coverslip and PDMS. This
strengthened the adhesion of the coverslip and PDMS, and inhibited coverslip
detachment from the PDMS. Third, a coverslip alcohol wash was removed from the
protocol. This coverslip wash might have affected the attachment between the glass
coverslip and PDMS. This process was replaced by cleaning the coverslip with air
prior to coverslip attachment to PDMS. Lastly, the tubing at the entry and exit ports
was sealed with PDMS. This increased the bonding between the tubing and PDMS,
and decreased leakage at the ports. These structural changes led to an increase in
device functionality. The devices could withstand higher flow rates, and could be
reused without a loss in device performance.

Functional flow rates increased for microfluidic device
Functional flow rates for the device were determined by experimental and
quantitative methods. This was completed by using PBS, in conjunction with a dye,
and by using Poisseuille’s law. The PBS and dye mixture was used to visualize
leakage through the device. Structural changes in the device increased the functional
flow rates for the device. Initially, the device had small amounts of success at low
flow rates. The coverslip would detach from the device, or the device would
experience high amounts of leakage. The functional flow rates increased from 10
microliters/min to flow rates of 50 microliters/min and higher. These experiments
provided a qualitative representation to determine a range of functional flow rates
for the device. These flow rates were then verified using quantitative calculations.
Poisseuille’s Law was used to calculate the maximum functional flow rate for the
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channel based on channel parameters. Assuming a maximum pressure of 300kPa,
the maximum flow rate was determined to be 1.23e13 microliters/min. These
calculations were used to ensure that the qualitatively determined flow rates were
less than the calculated maximum flow rate. After determining functional flow rates
for the device, flow rates that model in vivo flow rates were determined. A range of
in vivo flow velocities was given from a study conducted by Frees et al (2). This
range was used to calculate viable flow rates based on the channel parameters. This
range was determined to be from .75-3.75 microliters/min. These flow rates were
determined to be used in 2-NBDG experimentation.

Improvements in cell culturing allows for cell attachment within channel
Several adjustments in cell culturing techniques initiated cell attachment
within the channel. The cells were first cultured on a glass coverslip prior to
attachment with the PDMS mold. This method of cell culturing had no success. It
inhibited bonding between the coverslip and PDMS, and prevented formation of the
channel. Higher success was observed when injecting cells inside the channel after
the device had already been fabricated. This method did not interfere with the
bonding of the PDMS and coverslip. To inject cells inside the channel, a syringe
pump was used at a uniform flow rate. This method was problematic because no
cells were observed inside the channel after pumping. The flow rates for the syringe
pump were slow. This might have allowed for cell accumulation inside the tubing or
in the bottom of the syringe. The second method for cell injection involved injecting
cells manually with a syringe and a small piece of tubing inserted at the entry port.
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Cells were visualized inside the channel after injection with this method. The cell
count was increased to 6,000,000 cells/ml to improve cell visualization inside the
channel, and gelatin improved cell attachment inside the channel. After injection,
cells showed a tendency to exit the channel due to capillary action. Capillary action
is the result of high pressure inside the channel. To keep cells from exiting the
channel, the tubing was capped or adjusted. The cells could also be removed if the
media was perfused to quickly. A slow perfusion rate was chosen to inhibit this
effect. Incubation time also affected the results of this study. In one experiment, the
cells were cultured inside the channel for 72 hours. Cells accumulated within the
channel, and obstructed 2-NBDG flow during imaging. It was determined that the
incubation time should be decreased to ensure proper flow mechanics within the
channel.

Figure 3. a) Brightfield image of the microfluidic channel prior to cell injection (4X).
b) Brightfield image of the microfluidic channel injected with 4T1 cells (10X).
2-NBDG fluorescence observed at .5 microliters/min
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Fluorescence was observed as 2-NBDG was flowed through the microfluidic
device. This flow rate was chosen so that the cells would not be removed upon fluid
flow, and it modeled in vivo blood flow rates. An increase in fluorescence was
observed as 2-NBDG entered the channel. The highest intensity of fluorescence is
observed after 20 minutes of 2-NBDG flow. The intensity of 2-NBDG fluorescence
decreased as the remaining 2-NBDG was removed with glucose free media. The
remaining cells fluoresced visibly. The cells showed higher fluorescence than its
surrounding environment. The concentration of 2-NBDG could have been increased
to increase fluorescence intensity observed for the cells. Only one flow rate was
tested for 2-NBDG imaging. To determine the effect of flow rates on glucose uptake,
multiple flow rates should be testing in the future. These flow rates should be
chosen based on the in vivo flow rates previously determined.
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Figure 4. a) Brightfield image post 4T1 cell injection (10X). b) Image of cells 24
hours post incubation and prior to 2-NBDG flow (4X). c) Image of cells after 20 mins
of 2-NBDG flow (10X). d) Image of cells after washing with glucose free media (10X).
Conclusion
Measurement of glucose uptake is important in determining tumor response
to radiation. We have shown that the microfluidic device manufactured in this study
is a suitable device in allowing 2-NBDG flow. We have determined in vivo flow rates
for future experimentation. In addition, we have described valuable experimental
techniques for the continuation of this study in applying varying flow rates and
measuring glucose uptake. Future studies must be conducted with increasing flow
rates to determine the effect on glucose uptake. Previous studies have shown
valuable indications that 2-NBDG can be successful as a biomarker for measuring
glucose uptake in the future. The continuation of this study will be important in
determining initial metabolic demand, and thus, providing clinical significance in
staging cancers and determining the response of radiation therapy.

12

References
1. Rajaram N, Frees A, Fontanella A, Zhong J, Hansen K, Dewhirst M et al.
Delivery Rate Affects Uptake of a Fluorescent Glucose Analog in Murine
Metastatic Breast Cancer. PLoS ONE. 2013;8(10):e76524.
2. Frees A, Rajaram N, McCachren S, Fontanella A, Dewhirst M, Ramanujam N.
Delivery-Corrected Imaging of Fluorescently-Labeled Glucose Reveals
Distinct Metabolic Phenotypes in Murine Breast Cancer. PLoS ONE.
2014;9(12):e115529.
3. Hutcheson J, Powless A, Majid A, Claycomb A, Fritsch I, Balachandran K et al.
High-throughput microfluidic line scan imaging for cytological
characterization. Proc SPIE [Internet]. 2016 [cited 3 May 2016];9320:1-7.
Available from:
http://spie.org/Publications/Proceedings/Paper/10.1117/12.2079946
4. 2-NBDG (2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose)
[Internet]. Thermofisher.com. 2016 [cited 25 April 2016]. Available from:
https://www.thermofisher.com/order/catalog/product/N13195
5. Mims J, Bansal N, Bharadwaj M, Chen X, Molina A, Tsang A et al. Energy
Metabolism in a Matched Model of Radiation Resistance for Head and Neck
Squamous Cell Cancer. Radiation Research. 2015;183(3):291-304.
6. Chen A, Chu W, Gu Y, Cunnhingham C. Probing Early Tumor Response to
Radiation Therapy Using Hyperpolarized [1-13C]pyruvate in MDA-MB-231
Xenografts. PLoS ONE. 2013;8(2):e56551.
7. Han Z, Fu A, Wang H, Diaz R, Geng L, Onishko H et al. Noninvasive assessment
of cancer response to therapy. Nature Medicine. 2008;14(3):343-349.
8. Moding E, Kastan M, Kirsch D. Strategies for optimizing the response of
cancer and normal tissues to radiation. Nature Reviews Drug Discovery.
2013;12(7):526-542.
9. Asgari Y, Zabihinpour Z, Salehzadeh-Yazdi A, Schreiber F, Masoudi-Nejad A.
Alterations in cancer cell metabolism: The Warburg effect and metabolic
adaptation. Genomics. 2015.

13

Acknowledgements

I would like to acknowledge Dr. Rajaram and Dr. Puvanakrishnan for their
mentoring and support throughout this project. I would also like to thank Dr.
Balachandran and Josh Hutcheson for providing information in microfluidics. I
would also like to thank the Honors College Research Grant for funding this project.

14

